Taipeibio Co., Ltd

Taipeibio is the pioneer of regenerative-collagen driven tissue regeneration technologies, and can repair various bone defects including bone, joint, ligament and cartilage. The established market has only decade-old tech and non adequately to fit the patient's need. Founder Dr. Thomas Lai is well connected within the Harvard and MIT research community and has developed an advanced bone and joint regeneration platform proofed least risk and highest efficacy. We won the third prize from RESI innovation challenges in Boston in 2018, and have established comprehensive IP protection in 40 countries. We will perform IP licensing strategy in the wake of the FDA certification is cleared.